Erschienen in:
03.08.2021 | Trauma Surgery
Intertrochanteric fracture fixation in solid organ transplant patients: outcomes and survivorship
verfasst von:
Michael J. VanWagner, Steven B. Porter, Aaron C. Spaulding, Glenn G. Shi, Benjamin K. Wilke, Cameron K. Ledford
Erschienen in:
Archives of Orthopaedic and Trauma Surgery
|
Ausgabe 10/2022
Einloggen, um Zugang zu erhalten
Abstract
Background
Solid organ transplantation (SOT) recipients have complex medical and surgical risk factors; however, the outcomes of these patients undergoing surgical fixation of hip fractures are unknown. This study sought to evaluate SOT patients’ outcomes and survivorship after intertrochanteric (IT) fracture fixation.
Methods
A retrospective review identified 12 SOT patients who underwent cephalomedullary (CMN) nail fixation for IT fractures and were matched (1:2) to a cohort of 24 non-SOT IT fracture patients. Perioperative results and complications, mortality/patient survivorship, and clinical outcomes were compared between the cohorts.
Results
The time from presentation to surgical fixation was within 48 h of presentation for the non-SOT patients, while only 75% of SOT patients underwent surgery within 48 h of presentation (p = 0.034). The 90-day readmission rate for SOT patients was 25% versus 13% in the non-SOT group (p = 0.38). Similarly, the SOT cohort experienced a higher rate of major medical complication (25% vs. 13%, p = 0.38). There were two (16%) reoperations in the SOT group and three (13%) in the non-SOT matched group (p = 0.99). Respectively, the 90-day and 1-year estimated patient survivorship was similar between the two cohorts: SOT patients with 92% (95% CI 54–99%) and 73% (95% CI 24–93%) versus 86% (95% CI 62–95%) and 72% (95% CI 47–86%, HR 0.92, 95% CI 0.18–4.62, p = 0.92) in non-SOT patients.
Conclusion
SOT patients who underwent CMN fixation for IT fractures required more time from hospital presentation to surgical management than non-SOT patients. Although not statistically significant, SOT patients demonstrated more acute complications and readmissions, but similar mortality compared to those without transplant.